Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/24/2025

Management of Triple-Negative Breast Cancer

Systemic Therapy Recommendations

  • The National Comprehensive Cancer Network recommends that tumors ≥2cm in diameter warrant adjuvant chemotherapy, even in node-negative disease, as this represents a high-risk feature in triple-negative breast cancer 1, 2, 3, 4, 5, 6, 7.

Radiation Therapy Considerations

  • The National Comprehensive Cancer Network suggests that post-mastectomy radiation is generally not recommended for node-negative tumors <5cm with clear margins (≥1mm) 1, 2, 3.
  • The National Comprehensive Cancer Network recommends considering post-mastectomy radiation for high-risk features, including close margins (<1mm) 1, 2, 3, tumors ≥2cm 1, 2, 4, 5, 6, 7, premenopausal status 1, 2, 4, 5, 6, 7, lymphovascular invasion 1, 2, 4, 5, 6, 7, and triple-negative subtype specifically 1, 2, 4, 5, 6, 7.
  • The National Comprehensive Cancer Network recommends considering radiation therapy after breast-conserving surgery for TNBC management, as TNBC shows increased risk of locoregional recurrence even with tumors ≤5cm 1, 2, 4, 5, 6, 7.

Critical Pitfalls to Avoid

  • The National Comprehensive Cancer Network advises against undertreating based solely on node-negative status, as triple-negative biology and tumor size ≥2cm are independent high-risk features 1, 2, 3.
  • The National Comprehensive Cancer Network recommends considering radiation therapy, as TNBC has higher locoregional recurrence rates than other subtypes 1, 2.

REFERENCES

1

invasive breast cancer version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

2

invasive breast cancer version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

3

nccn guidelines insights: breast cancer, version 1.2017. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

4

breast cancer version 2.2015. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2015

5

breast cancer version 2.2015. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2015

6

breast cancer version 2.2015. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2015

7

invasive breast cancer version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016